17,283 followers
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma https://t.co/Qvl1M2Z9Vq https://t.co/MXTBTeBkty
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma https://t.co/Qvl1M2Z9Vq https://t.co/MXTBTeBkty
Safety efficacy of Immune Check point Inhibitors should be considere before its use.
New research: Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma: Immune checkpoint inhibitors (ICIs) such as anti-programmed death 1 (PD-1) receptor monoclonal antibody has been shown… https://t.